Bilaketaren emaitzak - VanBlargan, Laura

Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity nork VanBlargan, Laura A., Goo, Leslie, Pierson, Theodore C.

Testu osoa Testu osoa Testu osoa

A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis nork Goo, Leslie, VanBlargan, Laura A., Dowd, Kimberly A., Diamond, Michael S., Pierson, Theodore C.

Testu osoa Testu osoa Testu osoa

The Type-Specific Neutralizing Antibody Response Elicited by a Dengue Vaccine Candidate Is Focused on Two Amino Acids of the Envelope Protein nork VanBlargan, Laura A., Mukherjee, Swati, Dowd, Kimberly A., Durbin, Anna P., Whitehead, Stephen S., Pierson, Theodore C.

Testu osoa Testu osoa Testu osoa

An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections nork VanBlargan, Laura A., Himansu, Sunny, Foreman, Bryant M., Ebel, Gregory D., Pierson, Theodore C., Diamond, Michael S.

Testu osoa Testu osoa Testu osoa

Context-Dependent Cleavage of the Capsid Protein by the West Nile Virus Protease Modulates the Efficiency of Virus Assembly nork VanBlargan, Laura A., Davis, Kaitlin A., Dowd, Kimberly A., Akey, David L., Smith, Janet L., Pierson, Theodore C.

Testu osoa Testu osoa Testu osoa

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies nork VanBlargan, Laura, Errico, John, Halfmann, Peter, Zost, Seth, Crowe, James, Purcell, Lisa, Kawaoka, Yoshihiro, Corti, Davide, Fremont, Daved, Diamond, Michael

Testu osoa Testu osoa Testu osoa

Dengue Virus Serotype 1 Conformational Dynamics Confers Virus Strain-Dependent Patterns of Neutralization by Polyclonal Sera nork VanBlargan, Laura A., Milutinovic, Pavle S., Goo, Leslie, DeMaso, Christina R., Durbin, Anna P., Whitehead, Stephen S., Pierson, Theodore C., Dowd, Kimberly A.

Testu osoa Testu osoa Testu osoa

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies nork VanBlargan, Laura A., Errico, John M., Halfmann, Peter J., Zost, Seth J., Crowe, James E., Purcell, Lisa A., Kawaoka, Yoshihiro, Corti, Davide, Fremont, Daved H., Diamond, Michael S.

Testu osoa Testu osoa Testu osoa

A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice nork Malonis, Ryan J., Georgiev, George I., Haslwanter, Denise, VanBlargan, Laura A., Fallon, Georgia, Vergnolle, Olivia, Cahill, Sean M., Harris, Richard, Cowburn, David, Chandran, Kartik, Diamond, Michael S., Lai, Jonathan R.

Testu osoa Testu osoa Testu osoa

Binding of IFIT1 by IFIT3 modulates protein stability and RNA binding specificity nork Johnson, Britney, VanBlargan, Laura A., Xu, Wei, White, James P., Shan, Chao, Shi, Pei-Yong, Zhang, Rong, Adhikari, Jagat, Gross, Michael L., Leung, Daisy. W., Diamond, Michael S., Amarasinghe, Gaya K.

Testu osoa Testu osoa Testu osoa

Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization nork Liu, Zhuoming, VanBlargan, Laura A., Bloyet, Louis-Marie, Rothlauf, Paul W., Chen, Rita E., Stumpf, Spencer, Zhao, Haiyan, Errico, John M., Theel, Elitza S., Liebeskind, Mariel J., Alford, Brynn, Buchser, William J., Ellebedy, Ali H., Fremont, Daved H., Diamond, Michael S., Whelan, Sean P. J.

Testu osoa Testu osoa Testu osoa

Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein nork Suryadevara, Naveenchandra, Shrihari, Swathi, Gilchuk, Pavlo, VanBlargan, Laura A., Binshtein, Elad, Zost, Seth J., Nargi, Rachel S., Sutton, Rachel E., Winkler, Emma S., Chen, Elaine C., Fouch, Mallorie E., Davidson, Edgar, Doranz, Benjamin J., Carnahan, Robert H., Thackray, Larissa B., Diamond, Michael S., Crowe, James E.

Testu osoa Testu osoa Testu osoa

Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization nork Liu, Zhuoming, VanBlargan, Laura A., Bloyet, Louis-Marie, Rothlauf, Paul W., Chen, Rita E., Stumpf, Spencer, Zhao, Haiyan, Errico, John M., Theel, Elitza S., Liebeskind, Mariel J., Alford, Brynn, Buchser, William J., Ellebedy, Ali H., Fremont, Daved H., Diamond, Michael S., Whelan, Sean P.J.

Testu osoa Testu osoa Testu osoa

Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses nork VanBlargan, Laura A., Errico, John M., Kafai, Natasha M., Burgomaster, Katherine E., Jethva, Prashant N., Broeckel, Rebecca M., Meade-White, Kimberly, Nelson, Christopher A., Himansu, Sunny, Wang, David, Handley, Scott A., Gross, Michael L., Best, Sonja M., Pierson, Theodore C., Fremont, Daved H., Diamond, Michael S.

Testu osoa Testu osoa Testu osoa

mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2 nork Darling, Tamarand L., Ying, Baoling, Whitener, Bradley, VanBlargan, Laura A., Bricker, Traci L., Liang, Chieh-Yu, Joshi, Astha, Bamunuarachchi, Gayan, Seehra, Kuljeet, Schmitz, Aaron J., Halfmann, Peter J., Kawaoka, Yoshihiro, Elbashir, Sayda M., Edwards, Darin K., Thackray, Larissa B., Diamond, Michael S., Boon, Adrianus C.M.

Testu osoa Testu osoa Testu osoa

Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein nork Suryadevara, Naveenchandra, Shrihari, Swathi, Gilchuk, Pavlo, VanBlargan, Laura A., Binshtein, Elad, Zost, Seth J., Nargi, Rachel S., Sutton, Rachel E., Winkler, Emma S., Chen, Elaine C., Fouch, Mallorie E., Davidson, Edgar, Doranz, Benjamin J., Chen, Rita E., Shi, Pei-Yong, Carnahan, Robert H., Thackray, Larissa B., Diamond, Michael S., Crowe, James E.

Testu osoa Testu osoa Testu osoa

A potently neutralizing anti-SARS-CoV-2 antibody inhibits variants of concern by binding a highly conserved epitope nork VanBlargan, Laura, Adams, Lucas, Liu, Zhuoming, Chen, Rita E, Gilchuk, Pavlo, Raju, Saravanan, Smith, Brittany, Zhao, Haiyan, Case, James Brett, Winkler, Emma S, Whitener, Bradley, Droit, Lindsay, Aziati, Ismael, Shi, Pei-Yong, Creanga, Adrian, Pegu, Amarendra, Handley, Scott, Wang, David, Boon, Adrianus, Crowe, James E., Whelan, Sean P. J., Fremont, Daved, Diamond, Michael

Testu osoa Testu osoa Testu osoa

Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system nork Zhang, Jason Z., Yeh, Hsien-Wei, Walls, Alexandra C., Wicky, Basile I.M., Sprouse, Kaiti, VanBlargan, Laura A., Treger, Rebecca, Quijano-Rubio, Alfredo, Pham, Minh N., Kraft, John C., Haydon, Ian C., Yang, Wei, DeWitt, Michelle, Chow, Cameron, Carter, Lauren, Wener, Mark H., Stewart, Lance, Veesler, David, Diamond, Michael S., Baker, David

Testu osoa Testu osoa Testu osoa

Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains nork Ying, Baoling, Whitener, Bradley, VanBlargan, Laura A., Hassan, Ahmed O., Shrihari, Swathi, Liang, Chieh-Yu, Karl, Courtney E., Mackin, Samantha, Chen, Rita E., Kafai, Natasha M., Wilks, Samuel H., Smith, Derek J., Carreño, Juan Manuel, Singh, Gagandeep, Krammer, Florian, Carfi, Andrea, Elbashir, Sayda, Edwards, Darin K., Thackray, Larissa B., Diamond, Michael S.

Testu osoa Testu osoa Testu osoa

Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity nork Chen, Rita E., Smith, Brittany K., Errico, John M., Gordon, David N., Winkler, Emma S., VanBlargan, Laura A., Desai, Chandni, Handley, Scott A., Dowd, Kimberly A., Amaro-Carambot, Emerito, Cardosa, M. Jane, Sariol, Carlos A., Kallas, Esper G., Sékaly, Rafick-Pierre, Vasilakis, Nikos, Fremont, Daved H., Whitehead, Stephen S., Pierson, Theodore C., Diamond, Michael S.

Testu osoa Testu osoa Testu osoa